middle.news
CMS Sets $390 Medicare Price for PromarkerD, Paving US Market Entry
10:11am on Wednesday 26th of November, 2025 AEDT
•
Healthcare
Read Story
CMS Sets $390 Medicare Price for PromarkerD, Paving US Market Entry
10:11am on Wednesday 26th of November, 2025 AEDT
Key Points
US Medicare reimbursement set at $390.75 for next-gen PromarkerD test
CMS pricing supports broader patient access and private payer negotiations
PromarkerD predicts diabetic kidney disease risk up to four years early
Potential to impact care for 32 million US adults with diabetes
Read Story
middle.
Tap to Read
Tap the card to read the full analysis
about
Proteomics International Laboratories (ASX:PIQ)
OPEN ARTICLE